FDA Inspection 964409 — Michael T. Collins, M.D.
The FDA completed an inspection of Michael T. Collins, M.D. on February 2, 2016 in Bethesda, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 2, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bethesda, MD (United States)
Additional Details
Clinical Investigator (CI)